Transition to value-based reimbursement is essential for Health disparities

Value-based reimbursement inspires clinicians to care for the whole person, who is essential to addressing health disparities confirmed by claims data from the COVID-19 crisis, CMS says. Health disparities confirmed by Medicare claims data for the period of the COVID-19 crisis underscore the need to transition to value-based reimbursement, according to CMS. Health disparities evident in the […]

Read More.. Transition to value-based reimbursement is essential for Health disparities

Telemedicine reimbursement and healthcare fraud prevention laws

Policymakers of the US quickly took action in this COVID-19 pandemic to relaxed long-standing healthcare regulations which include telemedicine reimbursement and healthcare fraud prevention laws. Moreover, the government and aligned organizations have developed temporary health policies to support the industry’s response to the pandemic. Telemedicine reimbursement policy During this pandemic, most of the practices opt […]

Read More.. Telemedicine reimbursement and healthcare fraud prevention laws

Quality Payment Program Performance Results

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) enforced CMS to implement an incentive program called the Quality Payment Program as MACRA ended the Sustainable Growth Rate (SGR) formula, which significantly cut payment rates for participating Medicare clinicians. Now, clinicians can choose the following ways to participate in the Quality Payment Program: Merit-based […]

Read More.. Quality Payment Program Performance Results

Emergency Use Authorization of Medical Products

Recently, the Secretary of the Department of Health and Human Services (HHS) determined, according to section 564 of the Federal Food, Drug and Cosmetic (FD&C) Act, that there is a public health emergency, which has a serious potential to influence the health as well as the national security of citizens of the U.S. staying in other […]

Read More.. Emergency Use Authorization of Medical Products